Mix & Match of Different Vaccines is Safe and Elicits Robust Antibody Response, says AIG Hospitals’ Study, The first pilot study from India analyzing COVAXIN – COVISHEILD mixed doses
Hyderabad, 3rd Janusury 2022 (GNI): The third COVID-wave led by the Omicron variant has started in India. Although the initial data indicates that this wave will be milder than the previous Delta one with less…